• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑转移瘤的生长动力学可区分放射性坏死与复发。

Growth dynamics of brain metastases differentiate radiation necrosis from recurrence.

作者信息

Ocaña-Tienda Beatriz, Pérez-Beteta Julián, Molina-García David, Asenjo Beatriz, Ortiz de Mendivil Ana, Albillo David, Pérez-Romasanta Luís A, González Del Portillo Elisabeth, Llorente Manuel, Carballo Natalia, Arana Estanislao, Pérez-García Víctor M

机构信息

Mathematical Oncology Laboratory, University of Castilla-La Mancha, Ciudad Real, Spain.

Department of Radiology, Hospital Regional Universitario Carlos Haya, Málaga, Spain.

出版信息

Neurooncol Adv. 2022 Dec 8;5(1):vdac179. doi: 10.1093/noajnl/vdac179. eCollection 2023 Jan-Dec.

DOI:10.1093/noajnl/vdac179
PMID:36726366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9887079/
Abstract

BACKGROUND

Radiation necrosis (RN) is a frequent adverse event after fractionated stereotactic radiotherapy (FSRT) or single-session stereotactic radiosurgery (SRS) treatment of brain metastases (BMs). It is difficult to distinguish RN from progressive disease (PD) due to their similarities in the magnetic resonance images. Previous theoretical studies have hypothesized that RN could have faster, although transient, growth dynamics after FSRT/SRS, but no study has proven that hypothesis using patient data. Thus, we hypothesized that lesion size time dynamics obtained from growth laws fitted with data from sequential volumetric measurements on magnetic resonance images may help in discriminating recurrent BMs from RN events.

METHODS

A total of 101 BMs from different institutions, growing after FSRT/SRS (60 PDs and 41 RNs) in 86 patients, displaying growth for at least 3 consecutive MRI follow-ups were selected for the study from a database of 1031 BMs. The 3 parameters of the Von Bertalanffy growth law were determined for each BM and used to discriminate statistically PDs from RNs.

RESULTS

Growth exponents in patients with RNs were found to be substantially larger than those of PD, due to the faster, although transient, dynamics of inflammatory processes. Statistically significant differences ( < .001) were found between both groups. The receiver operating characteristic curve (AUC = 0.76) supported the ability of the growth law exponent to classify the events.

CONCLUSIONS

Growth law exponents obtained from sequential longitudinal magnetic resonance images after FSRT/SRS can be used as a complementary tool in the differential diagnosis between RN and PD.

摘要

背景

放射性坏死(RN)是脑转移瘤(BM)分次立体定向放射治疗(FSRT)或单次立体定向放射外科治疗(SRS)后常见的不良事件。由于磁共振图像上两者表现相似,因此很难将RN与疾病进展(PD)区分开来。以往的理论研究推测,RN在FSRT/SRS后可能具有更快(尽管是短暂的)生长动力学,但尚无研究使用患者数据证实这一假设。因此,我们推测,根据磁共振图像上连续体积测量数据拟合生长规律所获得的病变大小时间动态变化,可能有助于区分复发性BM和RN事件。

方法

从1031例BM的数据库中,选取86例患者中在FSRT/SRS后生长的101例BM(60例PD和41例RN),这些BM在至少连续3次MRI随访中显示有生长,用于本研究。确定每个BM的冯·贝塔朗菲生长规律的3个参数,并用于从统计学上区分PD和RN。

结果

由于炎症过程的动力学更快(尽管是短暂的),发现RN患者的生长指数显著大于PD患者。两组之间存在统计学显著差异(<0.001)。受试者工作特征曲线(AUC = 0.76)支持生长规律指数对事件进行分类的能力。

结论

FSRT/SRS后从连续纵向磁共振图像获得的生长规律指数,可作为鉴别RN和PD的辅助工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdb/9887079/e5fcfbe2e8dc/vdac179_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdb/9887079/45d39b14322d/vdac179_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdb/9887079/776d2f05125e/vdac179_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdb/9887079/e5fcfbe2e8dc/vdac179_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdb/9887079/45d39b14322d/vdac179_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdb/9887079/776d2f05125e/vdac179_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdb/9887079/e5fcfbe2e8dc/vdac179_fig3.jpg

相似文献

1
Growth dynamics of brain metastases differentiate radiation necrosis from recurrence.脑转移瘤的生长动力学可区分放射性坏死与复发。
Neurooncol Adv. 2022 Dec 8;5(1):vdac179. doi: 10.1093/noajnl/vdac179. eCollection 2023 Jan-Dec.
2
Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases.大体积脑转移瘤采用高生物等效剂量的立体定向放射外科或分次立体定向放射治疗后的放射性坏死
Biology (Basel). 2023 Apr 26;12(5):655. doi: 10.3390/biology12050655.
3
Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach.脑转移瘤放射治疗后放射性坏死:一种计算方法。
PLoS Comput Biol. 2024 Jan 30;20(1):e1011400. doi: 10.1371/journal.pcbi.1011400. eCollection 2024 Jan.
4
Salvage Surgical Resection after Linac-Based Stereotactic Radiosurgery for Newly Diagnosed Brain Metastasis.立体定向放射外科治疗初诊脑转移瘤后行挽救性手术切除。
Curr Oncol. 2021 Dec 9;28(6):5255-5265. doi: 10.3390/curroncol28060439.
5
FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study.立体定向放射治疗与射波刀治疗脑转移瘤——局部控制和放射性坏死的差异——一项容积研究
Front Oncol. 2020 Sep 30;10:559193. doi: 10.3389/fonc.2020.559193. eCollection 2020.
6
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis.分阶段术前立体定向放射治疗脑转移瘤患者:多机构分析。
J Neurooncol. 2022 Sep;159(2):389-395. doi: 10.1007/s11060-022-04073-w. Epub 2022 Jun 25.
7
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases.比较可切除脑转移瘤患者术前与术后单次及多次分割立体定向放射治疗的效果。
Clin Transl Radiat Oncol. 2022 Nov 9;38:117-122. doi: 10.1016/j.ctro.2022.11.004. eCollection 2023 Jan.
8
Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis.对立体定向放射外科治疗脑转移瘤后增大的病变进行活检,常显示放射性坏死。
Neuro Oncol. 2017 Oct 1;19(10):1391-1397. doi: 10.1093/neuonc/nox090.
9
Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.单纯单次分割立体定向放射外科治疗(SRS)与手术切除联合SRS治疗大脑大转移瘤的多机构分析
Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):459-467. doi: 10.1016/j.ijrobp.2017.04.006. Epub 2017 Apr 11.
10
Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.接受立体定向放射外科治疗后局部或区域性复发性脑转移瘤患者的第二疗程立体定向放射外科治疗的临床结果。
J Neurooncol. 2013 Oct;115(1):37-43. doi: 10.1007/s11060-013-1191-6. Epub 2013 Jun 28.

引用本文的文献

1
Artificial intelligence in neuro-oncology: methodological bases, practical applications and ethical and regulatory issues.神经肿瘤学中的人工智能:方法学基础、实际应用以及伦理和监管问题。
Clin Transl Oncol. 2025 May 22. doi: 10.1007/s12094-025-03948-4.
2
The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.脑转移瘤管理中从诊断到治疗的放射性坏死困境。
Neuro Oncol. 2024 Mar 4;26(12 Suppl 2):S56-S65. doi: 10.1093/neuonc/noad188.
3
Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach.

本文引用的文献

1
Improving the diagnosis of radiation necrosis after stereotactic radiosurgery to intracranial metastases with conventional MRI features: a case series.提高常规 MRI 特征下立体定向放射外科治疗颅内转移瘤后放射性坏死的诊断:病例系列。
Cancer Imaging. 2022 Jul 6;22(1):33. doi: 10.1186/s40644-022-00470-6.
2
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
3
Radiomics in Oncology: A Practical Guide.肿瘤放射组学:实用指南。
脑转移瘤放射治疗后放射性坏死:一种计算方法。
PLoS Comput Biol. 2024 Jan 30;20(1):e1011400. doi: 10.1371/journal.pcbi.1011400. eCollection 2024 Jan.
4
Growth exponents reflect evolutionary processes and treatment response in brain metastases.生长指数反映了脑转移瘤中的进化过程和治疗反应。
NPJ Syst Biol Appl. 2023 Jul 21;9(1):35. doi: 10.1038/s41540-023-00298-1.
Radiographics. 2021 Oct;41(6):1717-1732. doi: 10.1148/rg.2021210037.
4
Classification of true progression after radiotherapy of brain metastasis on MRI using artificial intelligence: a systematic review and meta-analysis.利用人工智能对脑转移瘤放疗后MRI上真性进展进行分类:一项系统评价和荟萃分析。
Neurooncol Adv. 2021 Jul 1;3(1):vdab080. doi: 10.1093/noajnl/vdab080. eCollection 2021 Jan-Dec.
5
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.欧洲神经肿瘤学会(EANO)与欧洲肿瘤内科学会(ESMO)实体瘤脑转移患者诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Nov;32(11):1332-1347. doi: 10.1016/j.annonc.2021.07.016. Epub 2021 Aug 6.
6
Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: A systematic review on current evidences and predicting factors.立体定向放射外科治疗免疫治疗时代脑转移瘤的作用:当前证据和预测因素的系统评价。
Crit Rev Oncol Hematol. 2021 Sep;165:103431. doi: 10.1016/j.critrevonc.2021.103431. Epub 2021 Jul 27.
7
Epidemiology of brain metastases and leptomeningeal disease.脑转移瘤和软脑膜疾病的流行病学。
Neuro Oncol. 2021 Sep 1;23(9):1447-1456. doi: 10.1093/neuonc/noab101.
8
Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance.立体定向放射治疗后脑转移瘤的体积回归:时间进程、预测因素及意义
Front Oncol. 2021 Jan 8;10:590980. doi: 10.3389/fonc.2020.590980. eCollection 2020.
9
Universal scaling laws rule explosive growth in human cancers.通用标度律支配着人类癌症的爆发式生长。
Nat Phys. 2020 Dec;16(12):1232-1237. doi: 10.1038/s41567-020-0978-6. Epub 2020 Aug 10.
10
FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study.立体定向放射治疗与射波刀治疗脑转移瘤——局部控制和放射性坏死的差异——一项容积研究
Front Oncol. 2020 Sep 30;10:559193. doi: 10.3389/fonc.2020.559193. eCollection 2020.